Free Trial
NASDAQ:GOSS

Gossamer Bio (GOSS) Stock Price, News & Analysis

Gossamer Bio logo
$2.66 +0.08 (+2.90%)
As of 10:24 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Gossamer Bio Stock (NASDAQ:GOSS)

Key Stats

Today's Range
$2.57
$2.70
50-Day Range
$1.21
$2.59
52-Week Range
$0.66
$2.70
Volume
558,324 shs
Average Volume
2.04 million shs
Market Capitalization
$605.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
Consensus Rating
Buy

Company Overview

Gossamer Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

GOSS MarketRank™: 

Gossamer Bio scored higher than 76% of companies evaluated by MarketBeat, and ranked 254th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Gossamer Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Gossamer Bio has only been the subject of 2 research reports in the past 90 days.

  • Read more about Gossamer Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Gossamer Bio are expected to decrease in the coming year, from ($0.28) to ($0.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Gossamer Bio is -4.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Gossamer Bio is -4.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Gossamer Bio's valuation and earnings.
  • Percentage of Shares Shorted

    9.02% of the outstanding shares of Gossamer Bio have been sold short.
  • Short Interest Ratio / Days to Cover

    Gossamer Bio has a short interest ratio ("days to cover") of 7.8.
  • Change versus previous month

    Short interest in Gossamer Bio has recently increased by 9.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Gossamer Bio does not currently pay a dividend.

  • Dividend Growth

    Gossamer Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.02% of the outstanding shares of Gossamer Bio have been sold short.
  • Short Interest Ratio / Days to Cover

    Gossamer Bio has a short interest ratio ("days to cover") of 7.8.
  • Change versus previous month

    Short interest in Gossamer Bio has recently increased by 9.33%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Gossamer Bio has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Gossamer Bio this week, compared to 2 articles on an average week.
  • Search Interest

    17 people have searched for GOSS on MarketBeat in the last 30 days. This is an increase of 13% compared to the previous 30 days.
  • MarketBeat Follows

    Only 5 people have added Gossamer Bio to their MarketBeat watchlist in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Gossamer Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.70% of the stock of Gossamer Bio is held by insiders.

  • Percentage Held by Institutions

    81.23% of the stock of Gossamer Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Gossamer Bio's insider trading history.
Receive GOSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GOSS Stock News Headlines

Gossamer Bio to Present at Upcoming Investor Conferences
Gossamer Bio: A Critical Year Ahead
What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.tc pixel
See More Headlines

GOSS Stock Analysis - Frequently Asked Questions

Gossamer Bio's stock was trading at $0.9046 at the beginning of 2025. Since then, GOSS shares have increased by 186.3% and is now trading at $2.59.

Gossamer Bio, Inc. (NASDAQ:GOSS) posted its quarterly earnings data on Tuesday, August, 5th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.01. The company had revenue of $11.49 million for the quarter, compared to the consensus estimate of $4.12 million. Gossamer Bio had a negative net margin of 344.81% and a negative trailing twelve-month return on equity of 1,774.72%.

Gossamer Bio (GOSS) raised $230 million in an initial public offering (IPO) on Friday, February 8th 2019. The company issued 14,400,000 shares at $16.00 per share. BofA Merrill Lynch, Leerink Partners, Barclays and Evercore ISI acted as the underwriters for the IPO.

Gossamer Bio's top institutional shareholders include Acadian Asset Management LLC (3.14%), Geode Capital Management LLC (2.00%), Corient Private Wealth LLC (1.62%) and Monaco Asset Management SAM (1.56%). Insiders that own company stock include Faheem Hasnain, Richard Aranda, Bryan Giraudo, Laura Carter and Caryn Peterson.
View institutional ownership trends
.

Shares of GOSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gossamer Bio investors own include Voyager Therapeutics (VYGR), Waste Connections (WCN), American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
8/05/2025
Today
9/02/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GOSS
CIK
1728117
Fax
N/A
Employees
180
Year Founded
N/A

Price Target and Rating

High Price Target
$11.00
Low Price Target
$5.00
Potential Upside/Downside
+228.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$56.53 million
Net Margins
-344.81%
Pretax Margin
-353.62%
Return on Equity
-1,774.72%
Return on Assets
-46.73%

Debt

Debt-to-Equity Ratio
6.70
Current Ratio
4.40
Quick Ratio
4.40

Sales & Book Value

Annual Sales
$114.70 million
Price / Sales
5.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.20) per share
Price / Book
-12.95

Miscellaneous

Outstanding Shares
227,380,000
Free Float
212,146,000
Market Cap
$588.91 million
Optionable
Optionable
Beta
1.95

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:GOSS) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners